Molecular Diagnostic Market is projected to reach USD 50.13 billion by 2035
The molecular diagnostic market is expected to develop at a compound
annual growth rate (CAGR) of 9.6% from 2025 to 2035, from its estimated
valuation of USD 18.29 billion in 2024 to USD 50.13 billion by that time.
Numerous medical fields, such as infectious illness, cancer, genetic disorders,
and customized therapy, depend on it.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/molecular-diagnostic-market
GROWTH
DRIVERS
The growing
global burden of infectious diseases like HIV, TB, and other viral infections,
as well as the rising incidence of chronic problems like cancer, cardiovascular
disease, and neurological disorders, are the main factors propelling the
molecular diagnostics market. Early diagnosis, successful treatment, and
illness management all depend on the quick and precise identification of
pathogens and disease biomarkers made possible by the application of molecular
diagnostic tools. The World Health Organization (WHO) reports that cancer is
the second greatest cause of death globally, while infectious diseases continue
to rank among the top causes of morbidity and mortality, particularly in poorer
countries.
The market is
expanding dramatically as a result of ongoing technological developments.
Diagnostic analysis is becoming faster, more sensitive, and more specific
thanks to advancements in techniques like digital PCR, next-generation
sequencing (NGS), in situ hybridization (ISH), and isothermal nucleic acid
amplification technology (INAAT). For example, digital PCR offers greater
sensitivity and precision than classical PCR, making it possible to detect
uncommon mutations and less residual disease.
MARKET
SEGMENTATION:
By Product -
· Instruments
· Consumable
and Accessories
· Software
and Services
By Test Type
–
· Lab
Test
· POC
Test
· Home-Based/OTC Test
By Sample
Type –
· Blood, Serum, and Plasma
· Urine
· Other Sample Types (Saliva, Tissue, And
Swabs)
By
Technology –
· Polymerase
Chain Reaction
· Isothermal
Nucleic Acid Amplification
· DNA
Sequencing & Next-Generation Se
· In
Situ Hybridization
· DNA
Microarrays
· Other
Technologies
By
Application –
· Infectious
Disease Diagnostics
o Hepatitis
§ Hepatitis B
§ Hepatitis C
§ Other Hepatitis Diseases
o HIV
o CT/NG
o HAI
o HPV
o Tuberculosis
o Influenza
o Other Infectious Diseases
· Oncology
Testing
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Prostate Cancer
o Other Cancer Types
· Genetic
Testing
· Other
Applications
By End User
–
· Hospitals
& Clinics
· Academic & Research Institutes
· Blood Banks
· Other
End Users
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
Key
Players:
· bioMérieux
· Hologic,
Inc.
· QIAGEN
N.V.
· Thermo
Fisher Scientific Inc.
· Abbott
· Revvity,
Inc.
· Other
Key & Niche Players
For More Information about this Report @
https://www.xresearch.biz/shop/molecular-diagnostic-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment